Health Economics and Epidemiology Research Office - HE2RO

15/06/2026

New co-authored publication alert!

Risk Perception and Its Influence on Pre-Exposure Prophylaxis (PrEP) Uptake and Adherence Among Pharmacy-Based PrEP Users in South Africa: A Qualitative Study.

Click here to read the full article: https://www.heroza.org/publications/risk-perception-and-its-influence-on-pre-exposure-prophylaxis-prep-uptake-and-adherence-among-pharmacy-based-prep-users-in-south-africa-a-qualitative-study/the

15/06/2026

New policy brief alert!

Monitoring HIV viral load testing among mother-infant pairs: discordance and missed opportunities in the postpartum period.

Click here for the full brief: https://ow.ly/V1lH50ZbLZ9

12/06/2026

Our lenacapavir (LEN) modelling work was recently referenced in an NPR feature on HIV prevention in South Africa.
We are proud to see this work contributing to broader conversations on the potential impact of lenacapavir.
Click here to read more:

A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

10/06/2026

Scenes from SATB today - Clive Ramushu presented his oral poster titled: Pooling sputum specimens of people at high risk of TB reduces costs of Xpert Ultra TB testing: results from the TUTTPlus study in South Africa.

09/06/2026

Scenes from today at the conference - Pictured: Co-authors Khumo Modiba and Pauline Howell.

09/06/2026

Meet the team on the Ground at the 9th SATB conference. (From left to right) Mr Khumo Modiba, Dr Mmamapudi Kubjane, Ms Nelly Jinga, Prof Denise Evans (Wits) and Mr Clive Ramushu. Visit our website to learn more about them and their work https://ow.ly/LjrY50Z9jLv.

09/06/2026

Calling Johannesburg inner-city workplaces!

The Healthy Jozi study by Ezintsha is looking to partner with workplaces to support employee wellness and healthier working environments. See more details on the flyer.

If you are Interested, email: [email protected].

09/06/2026

Proudly representing at the 9th SA TB Conference this week. Meet our team: Mr Mathee Clive Ramushu, Mr Khumo Modiba and Dr Mmamapudi Kubjane. #

05/06/2026

📍Today | President Cyril Ramaphosa will officially launch the rollout of Lenacapavir, a groundbreaking long-acting injectable for HIV prevention.

This historic milestone strengthens South Africa’s HIV prevention efforts and expands access to innovative healthcare solutions, bringing the country closer to ending new HIV infections. Read more: zurl.co/laIbS

03/06/2026

What an incredible achievement! We are proud to be part of such an outstanding academic institution. Congratulations to everyone who has contributed to this remarkable milestone through their dedication, hard work and commitment to excellence. 🎉 🎉